Skip to content

A randomized controlled study of wearable devices combined with Baduanjin in the management of movement in metabolic syndrome

A randomized controlled study of wearable devices combined with Baduanjin in the management of movement in metabolic syndrome

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200005860
Enrollment
Unknown
Registered
2022-04-14
Start date
2022-04-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic syndrome

Interventions

control group:no intervention
Treatment group:Wearable devices combined with Baduanjin
Treatment group:Wearable devices

Sponsors

Guangdong Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: ?Age between 18 and 70 years old. ?Patients in the outpatient clinic and ward of the Department of Endocrinology of Guangdong Provincial Hospital of Traditional Chinese Medicine. ?Patients who meet the diagnosis of metabolic syndrome; and BMI = 24 kg/m2 . ?Those who signed the informed consent form.

Exclusion criteria

Exclusion criteria: ? Severe cardiac, hepatic and renal insufficiency (blood creatinine clearance <30 ml/min, alanine aminotransferase =2.5 times the upper limit of normal, total bilirubin =1.5 times the upper limit of normal; chronic cardiac insufficiency, cardiac function class III and above). ?Those who are not suitable for exercise such as severe myocardial ischemia, severe hypertensive disease and unstable blood sugar. ?Those who cannot cooperate with exercise such as post-stroke, joint and muscle diseases, lumbar spine diseases, etc. ?Secondary lipid, blood pressure and glucose abnormalities. ?Type 1 diabetes. ?Hyperthyroidism or hypothyroidism. ?Taking weight-impacting drugs such as glucocorticoids, birth control pills and diet pills. ?Those who cannot understand the content of the study and have difficulty accepting the research protocol.

Design outcomes

Primary

MeasureTime frame
HOMA-IR;

Secondary

MeasureTime frame
BMI;Blood glucose;TCM symptom score;Exercise adherence;Blood pressure;EQ-5D health index scale;Body fat rate;Blood fat;

Countries

China

Contacts

Public ContactZhenjie Liu
zhenjl@139.com13711758166

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026